H.R. 5127 · 114th Congress
Curb Opioid Misuse By Advancing Technology Act of 2016
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 114th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
GriffithSponsor10 cosponsors · 4 D, 6 R
R
Bilirakis
GC
D
Connolly
CC
R
Collins
BB
D
Boyle
MF
R
Fitzpatrick
BD
R
Dold
MV
D
Veasey
CS
R
Stewart
MB
R
Blackburn
FW
D
Wilson2 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill amends the Federal Food, Drug, and Cosmetic Act to extend the marketing exclusivity period for certain brand name drugs that the Food and Drug Administration approves: (1) on the basis of new clinical abuse potential studies, and (2) with labeling that characterizes the drug's abuse-deterrent properties.
What it does: CRS summary · Introduced in House · Apr 29, 2016
Curb Opioid Misuse By Advancing Technology Act of 2016
This bill amends the Federal Food, Drug, and Cosmetic Act to extend the marketing exclusivity period for certain brand name drugs that the Food and Drug Administration approves: (1) on the basis of new clinical abuse potential studies, and (2) with labeling that characterizes the drug's abuse-deterrent properties. This extension does not apply to the marketing exclusivity period for new chemical entities.
The bill also extends the marketing exclusivity period for generics of these drugs.Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Curb Opioid Misuse By Advancing Technology Act of 2016
Latest action (May 6, 2016): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Apr 29, 2016
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.